AdBio Partners, formerly known as Advent France Biotechnology, is an AMF-regulated venture capital firm based in Paris, France. Established in 2016, the firm focuses on early-stage investments in life sciences startups across Europe, particularly in therapeutics-oriented projects. AdBio Partners combines seed investments with strong entrepreneurial support to foster the growth of innovative enterprises. The firm has made 26 investments in countries including France, Belgium, Spain, and Ireland, managing two funds: AFB Seed Fund I and AFB FII. AdBio Partners collaborates with leading research institutions and technology transfer offices, leveraging a network of scientific and industrial partners, as well as international VC syndicates. The operational team comprises professionals with extensive experience in entrepreneurial ventures, scientific research, and financial management.
Is AdBio Partners the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with AdBio Partners, along with a list of other relevant VCs, is available on Hopohopo.io.
Stages
Seed
First ticket size
€1,000,000 - €5,000,000
When reaching out to AdBio Partners, founders should highlight the scientific rigor and translational potential of their technology, demonstrating a clear path from research to clinical or commercial milestones. Emphasize your team’s domain expertise and ability to navigate complex regulatory or development environments, as AdBio values operational excellence and credible execution. Articulate how your startup can leverage their network of research and industry partners to accelerate growth and de-risk development.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.